Company Profile
Sector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericEmployees
12Website
www.incannex.comCountry
🇦🇺 Australia
Unranked
IXHL
$3.28
+2.18% (24h)
Last updated: 1 second ago
Market Cap
$39.24M
Volume (24h)
25.28K
Last Close (7D)
$3.28
An Australian clinical-stage pharmaceutical company developing combination cannabinoid and psychedelic medicines for sleep apnea, general anxiety, PTSD, and traumatic brain injury.
52-Week Range